Research Paper Volume 15, Issue 7 pp 2631—2666
Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma
Figure 1. The expression of ARHGAP39 in HCC and other cancers. (A) Level of ARHGAP39 expression in a variety of cancer tissues (***p < 0.001, **p < 0.01, *p < 0.05). (B) ARHGAP39 mRNA levels in tumor and normal tissues based on the TCGA database (p = 1.462e−23). (C) Paired differential expression map of ARHGAP39 between HCC tissues and normal tissues based on the TCGA database (p = 1.924e−14). (D) The mRNA expression level of ARHGAP39 in tumor and normal tissues in the ICGC (p < 2.22e−16). (E) HCCDB analysis of aberrant expression of ARHGAP39 in HCC patients.